Morellic acidCAS# 5304-71-2 |
- Isomorellic acid
Catalog No.:BCN3074
CAS No.:5262-69-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 5304-71-2 | SDF | Download SDF |
PubChem ID | 54580250 | Appearance | Powder |
Formula | C33H36O8 | M.Wt | 560.7 |
Type of Compound | Miscellaneous | Storage | Desiccate at -20°C |
Synonyms | (-)-Morellic Acid | ||
Solubility | Soluble in chloroform and DMSO | ||
Chemical Name | (Z)-4-[(1S,2S,17S,19R)-12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4,6(11),9,12,15-pentaen-19-yl]-2-methylbut-2-enoic acid | ||
SMILES | CC(=CCC1=C2C(=C(C3=C1OC(C=C3)(C)C)O)C(=O)C4=CC5CC6C4(O2)C(C5=O)(OC6(C)C)CC=C(C)C(=O)O)C | ||
Standard InChIKey | COVMVPHACFXMAX-OYNOKLRGSA-N | ||
Standard InChI | InChI=1S/C33H36O8/c1-16(2)8-9-20-26-19(11-12-30(4,5)39-26)24(34)23-25(35)21-14-18-15-22-31(6,7)41-32(28(18)36,13-10-17(3)29(37)38)33(21,22)40-27(20)23/h8,10-12,14,18,22,34H,9,13,15H2,1-7H3,(H,37,38)/b17-10-/t18-,22+,32+,33-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Morellic acid has cytotoxic activity. 2. Morellic acid has anti-HIV-1 activity. 3. Morellic acid has antibacterial activity. |
Targets | HIV | Antifection |
Morellic acid Dilution Calculator
Morellic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.7835 mL | 8.9174 mL | 17.8348 mL | 35.6697 mL | 44.5871 mL |
5 mM | 0.3567 mL | 1.7835 mL | 3.567 mL | 7.1339 mL | 8.9174 mL |
10 mM | 0.1783 mL | 0.8917 mL | 1.7835 mL | 3.567 mL | 4.4587 mL |
50 mM | 0.0357 mL | 0.1783 mL | 0.3567 mL | 0.7134 mL | 0.8917 mL |
100 mM | 0.0178 mL | 0.0892 mL | 0.1783 mL | 0.3567 mL | 0.4459 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Scutebarbatine J
Catalog No.:BCN8134
CAS No.:960302-85-6
- T-5224
Catalog No.:BCC5383
CAS No.:530141-72-1
- Murralongin
Catalog No.:BCN5696
CAS No.:53011-72-6
- Salinomycin
Catalog No.:BCC1916
CAS No.:53003-10-4
- CDI (1,1′-Carbonyldiimidazole)
Catalog No.:BCC2809
CAS No.:530-62-1
- Sinapic acid
Catalog No.:BCN3539
CAS No.:530-59-6
- Syringic acid
Catalog No.:BCN5699
CAS No.:530-57-4
- 2,6-Dimethoxy-1,4-benzoquinone
Catalog No.:BCN5698
CAS No.:530-55-2
- Deoxyvasicinone
Catalog No.:BCN5697
CAS No.:530-53-0
- L-Picein
Catalog No.:BCC8336
CAS No.:530-14-3
- Indomethacin
Catalog No.:BCC3794
CAS No.:53-86-1
- Dehydroepiandrosterone
Catalog No.:BCN2202
CAS No.:53-43-0
- 9,13-Epidioxy-8(14)-abieten-18-oic acid
Catalog No.:BCN1426
CAS No.:5309-35-3
- Dichotomin
Catalog No.:BCN2836
CAS No.:53093-47-3
- Androsin
Catalog No.:BCN3842
CAS No.:531-28-2
- Coniferin
Catalog No.:BCN5700
CAS No.:531-29-3
- Scopolin
Catalog No.:BCN5701
CAS No.:531-44-2
- 7-Methoxycoumarin
Catalog No.:BCN2707
CAS No.:531-59-9
- Esculin
Catalog No.:BCN5904
CAS No.:531-75-9
- Coumarin-3-Carboxylic Acid
Catalog No.:BCC9220
CAS No.:531-81-7
- 4',7-Isoflavandiol
Catalog No.:BCN2855
CAS No.:531-95-3
- Boc-Pyr-OH
Catalog No.:BCC3329
CAS No.:53100-44-0
- Rapamycin (Sirolimus)
Catalog No.:BCC3592
CAS No.:53123-88-9
- Buprenorphine hydrochloride
Catalog No.:BCC5215
CAS No.:53152-21-9
Validation of an HPLC-MS-MS assay for determination of morellic acid in rat plasma: application to pharmacokinetic studies.[Pubmed:26071609]
J Chromatogr Sci. 2015 Nov-Dec;53(10):1695-700.
A selective and rapid high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS-MS) was developed for the quantification of Morellic acid in rat plasma. HPLC was performed using a Capcell MG C18 (50 x 4.6 mm, i.d., 5 microm) column, and isocratic elution with water-acetonitrile (20:80, v/v) at a flow rate of 0.5 mL/min. Sample preparation of analyte and internal standard (gambogic acid) involved liquid-liquid extraction using ethyl acetate-isopropanol (1:1, v/v) from 50 microL plasma. The precursor --> production transitions for analyte and IS were m/z 559.4 --> 471.3, and m/z 627.3 --> 583.3, respectively, and were monitored on a triple-quadrupole mass spectrometer, operating in negative ion scan mode. The method was validated across the dynamic concentration range of 20-7,500 ng/mL for Morellic acid, with a fast run time of 6.0 min. The analytical method measured concentrations of Morellic acid with accuracy (% bias) of =6.4% and precision (% RSD) of =14.0%. Morellic acid was stable during the battery of stability studies. Finally, the applicability of this assay has been successfully demonstrated in vivo pharmacokinetic studies in Sprague-Dawley rats. This method will therefore be useful for further preclinical and clinical pharmacokinetic studies of Morellic acid.